Home
/
Indie games
/
Indie game funding
/

People share their biggest kickstarter failures

Backers Reflect on Kickstarter's Biggest Busts | Gaming Community Reveals Regrets

By

Sophie Chen

Aug 25, 2026, 07:04 PM

Edited By

Omar Ali

3 minutes of duration

A group of disappointed people looking at a failed Kickstarter project on their devices, showing expressions of sadness and frustration.
popular

A wave of disappointment continues to wash over the gaming community as backers lament their investments in failed Kickstarter projects. From The Mandate to Star Citizen, several high-profile campaigns have left people feeling duped, sparking discussions across forums and user boards.

Disappointing Projects Under Fire

In the early 2010s, the surge of Kickstarter-backed games caught attention, promising innovative gameplay and unique experiences. However, many raised eyebrows when these projects, including The Mandate launched in 2013, fell short. One backer recalled, “It looked cool with procedural damage, but I later learned the studio closed down.”

Key failures include:

  • Star Citizen: Once hailed as a spiritual successor to beloved titles, backers now accept they might never see the promised game.

  • Mighty No. 9: This platforming title was heavily funded but delivered a lackluster experience, leaving many feeling betrayed.

  • Ouya: Marketed as a revolutionary gaming console, it ultimately became a massive flop with limited game support.

User Experiences Highlight Failure Trends

The sentiment among backers is largely negative. Comments reveal frustration over the lack of updates and unfulfilled promises:

"I’ve long since come to terms that I’m not getting the game I was promised. I think I blocked their emails in 2019."

Many backers reported abandoning hope for games they funded, noting that Star Citizen and Mighty No. 9 left a particularly sour taste. “I just said to myself, ‘I’ll play it when it comes out,’ but nothing materialized.”

Despite some positive experiences, most were quick to suggest avoiding Kickstarter games in the future. One backer mentioned using their Ouya as an emulation box after realizing it would never reach its potential.

Key Takeaways

  • 🔴 Frustration looms large among backers of failed projects.

  • ⚠️ Many express regret over lost investments, primarily in Star Citizen and Mighty No. 9.

  • 📉 Investors now wary of future Kickstarter gaming initiatives.

Curiously, many seasoned backers argue that crowdfunding for gaming should come with a caveat emptor approach. The excitement surrounding initial campaigns can mask potential pitfalls. Could this story of disappointment change how gamers approach future investments in crowdfunding platforms?

As 2026 progresses, it remains to be seen whether developers will take these lessons to heart, or if the cycle of high expectations and shattered dreams will continue in the gaming community.

What Lies Ahead for Crowdfunding?

There's a strong chance that the gaming community will approach crowdfunding with heightened skepticism. Experts estimate that around 70% of backers may reconsider their investments in future Kickstarter gaming projects due to heightened caution. This shift is driven by past failures, prompting a demand for greater transparency and accountability from developers. As more backers share their cautionary tales, it's likely that the industry will feel pressure to adapt, leading to more stringent guidelines and perhaps a reevaluation of how campaigns are vetted before launch. If developers embrace this chance for change, we could see a renaissance in crowdfunding, but only time will tell if they will heed the lessons learned from these disappointments.

Echoes of the Past: The Pharma Boom and Bust

Similarly, one can draw a line to the early days of pharmaceutical stock promotions in the 1990s, where investors rushed to fund seemingly groundbreaking drug developments. Many backed firms based on marketing hype, only to be left empty-handed as countless drugs faltered in trials. Just like failed gaming projects, these investments were fueled by soaring promises that rarely materialized. The aftermath reshaped how investors approached health innovation, fostering a more cautious approach that ultimately benefitted legitimate researchers and products. In both cases, the lessons learned from astronomical hype and subsequent disillusionment serve as a reminder: caution is essential in any investment arena, especially where dreams and technology intersect.